Clinical trial
CEST-based Biomarkers to Delineate the Epileptogenic Zone
NCT07316972 is registered in ClinicalTrials.gov with Fondation Ophtalmologique Adolphe de Rothschild as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CEST-based Biomarkers to Delineate the Epileptogenic Zone
- Lead sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 31, 2027
- Completion date
- January 31, 2030
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
epilepsy (treatment refractory)